An observational study in Patient Engagement; Community Health Workers, sponsored by NYU Langone Health. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2022-03-15.
Sponsored by NYU Langone Health · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 154 studies in Patient Participation with a site in United States — 27 open to participants now, 31 under way, none of them phase 3. Patient Participation · United States.
Among the 154 studies in Patient Participation with a site in United States, this one is the 3rd largest by enrollment of the 15 observational ones that give a count, is one of 6 that started in 2018, is one of 15 observational ones, and was the 45th registered.
409 studies on the registry are indexed under Patient Participation; 100 are open to participants now.
Browse Patient Participation studies →27 of the 154 studies in Patient Participation with a site in United States are open now. Recruiting first, the newest first:
University of Utah · Sites in United States
Ages 18+ · Women only · Healthy volunteers
William Brandenburg, MD · Sites in United States
Ages 18+ · Healthy volunteers
University of Nebraska · Sites in United States
Ages 15–18
University of Washington · Sites in United States
Ages 14+ · Healthy volunteers
Columbia University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 48 Patient Participation studies recruiting now, 32 (67%) set no upper age limit and 9 (19%) stop at 75 or younger; 10 take children under 18; 11 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
154 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 2 · Phase 3 2 · Phase 4 1
First in 2002; this study’s year is marked. 6 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 2,314 is above the median of 170 across 80 observational studies indexed under Patient Participation.
Median enrollment 130 across the 139 interventional studies, 257 across the 15 observational. Of the 114 that completed or were terminated, 42 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 154 have an industry lead sponsor. The 10 most frequent:
NYU Langone Health is the lead sponsor of 1,431 studies on the registry; 259 are open to participants now.
Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.
NYU Langone Health has 2 studies filed under Patient Participation — fewer than ten, so there is no comparison to draw.
13 of the studies in Patient Participation with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06989593Sarah SchlegelBreaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions | 2026-11 |
| NCT06246409University of FloridaModernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy | 2026-12 |
| NCT07489105Auburn UniversityForge AHEAD: Feasibility of Yoga to Improve Cognitive Function | 2026-12-31 |
| NCT06581484University of California, San FranciscoImproving Congenital Heart Disease Care | 2026-12-31 |
| NCT06358261Johns Hopkins UniversityStudy of a Diabetes Prevention Patient Activation Clinical Decision Support Tool | 2027-01-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 154 studies in Patient Participation with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is evaluating the effectiveness of the post-discharge program facilitated by the Community Health Worker program in the Emergency Department at NYU Langone Health Hospital - Brooklyn and testing different strategies to increase patient engagement in the program.
Patients who present for a visit at the Emergency Department at NYU Langone Brooklyn Hospital and who qualify for the Community Health Worker program assessment and enrollment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients in this arm will not be approached by community health workers during their visit to the Emergency Department.
Participants in this group will be approached by a community health worker during their visit to the Emergency Department with the goal of enrolling them in a comprehensive post-discharge program.
Other: Community Health Worker Assessment
Participants will be approached by a community health worker who will ask them to complete an assessment of needs and offer to enroll them in post-discharge services to help address the needs identified.
Service utilization
Number of services (emergency department visits, etc.) utilized by the patient.
Time frame: 1 year
Post-discharge program enrollment rate
Total number of patients who agree to enroll in the post-discharge program/total number of patients approached by community health workers.
Time frame: 1 year
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Feb 2018 to primary completion in Nov 2018, 9 months.
Of 42 non-industry observational studies under Patient Participation, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 37. This study's 9 months is below that.
Counting every sponsor, half of 44 studies reached it within 17 months; a quarter within 8 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.